相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deciphering the roles of miR-16-5p in malignant solid tumors
Liuyi Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Saife N. Lone et al.
MOLECULAR CANCER (2022)
Characterizing the Inflammatory Microenvironment in K14-HPV16 Transgenic Mice: Mast Cell Infiltration and MicroRNA Expression
Alexandra C. Costa et al.
CANCERS (2022)
MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype
Bruna M. Sugita et al.
CANCERS (2022)
Regulatory mechanism of miR-20a-5p expression in Cancer
Wei Huang et al.
CELL DEATH DISCOVERY (2022)
CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
Xi Chen et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)
Interplay betweenHMGAandTP53in cell cycle control along tumor progression
Nathalia Meireles Da Costa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing
Tianyu Guo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3
Xiaomin Qin et al.
CANCER LETTERS (2021)
Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer
Mohan Damodaran et al.
MOLECULAR BIOLOGY REPORTS (2021)
CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis
Ozel Capik et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2021)
miR-20a-5p inhibits endometrial cancer progression by targeting janus kinase 1
Ying He et al.
ONCOLOGY LETTERS (2021)
Androgens in prostate cancer: A tale that never ends
Zemin Hou et al.
CANCER LETTERS (2021)
Targeting the PI3K-AKT-mTOR Pathway in Castration Resistant Prostate Cancer: A Review Article
Jason Cham et al.
CLINICAL GENITOURINARY CANCER (2021)
MicroRNA-16-5p/BIMP1/NF-κB axis regulates autophagy to exert a tumor-suppressive effect on bladder cancer
Jiani He et al.
MOLECULAR MEDICINE REPORTS (2021)
Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer-A Multi-Institutional Study
Maria J. Stoen et al.
CANCERS (2021)
miRTargetLink 2.0-interactive miRNA target gene and target pathway networks
Fabian Kern et al.
NUCLEIC ACIDS RESEARCH (2021)
Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p
Hongyan Wang et al.
BIOENGINEERED (2021)
MiR-130b/TNF-alpha/NF-kappa B/VEGFA loop inhibits prostate cancer angiogenesis
H. Q. Mu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
miR-16-5p modulates the radiosensitivity of cervical cancer cells via regulating coactivator-associated arginine methyltransferase 1
Shumao Zhang et al.
PATHOLOGY INTERNATIONAL (2020)
miR-20a-5p/TGFBR2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis
Xiutao Fu et al.
FRONTIERS IN ONCOLOGY (2020)
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
A. H. Zedan et al.
SCIENTIFIC REPORTS (2020)
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy
Giuseppe Di Lorenzo et al.
ONCOLOGY (2020)
MicroRNA-16-5p regulates cell survival, cell cycle and apoptosis by targeting AKT3 in prostate cancer cells
Fang Wang et al.
ONCOLOGY REPORTS (2020)
YB-1 variant and androgen receptor axis-targeted agents in metastatic castration-resistant prostate cancer patients
Ana Afonso et al.
PHARMACOGENOMICS (2020)
Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway
Jian Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Towards DNA-damage induced autophagy: A Boolean model of p53-induced cell fate mechanisms
Shantanu Gupta et al.
DNA REPAIR (2020)
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
Gaetano Aurilio et al.
CELLS (2020)
miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2
Wei Tang et al.
JOURNAL OF SURGICAL RESEARCH (2019)
miR-150-5p represses TP53 tumor suppressor gene to promote proliferation of colon adenocarcinoma
Fang Liu et al.
SCIENTIFIC REPORTS (2019)
The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression
Hui Liu et al.
NEOPLASIA (2019)
Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
David Bidarra et al.
FRONTIERS IN ONCOLOGY (2019)
Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis
Tahereh Zeinali et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p
Ming Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells
Fang Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer
Wenyan Zhao et al.
CANCER MEDICINE (2018)
miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer
Xiaoxiang Chen et al.
AGING-US (2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer
Rafael Sebastian Fort et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
Clinical significance of miRNA host gene promoter methylation in prostate cancer
Kristina Daniunaite et al.
HUMAN MOLECULAR GENETICS (2017)
A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer
Rhonda Daniel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
PANEL OF 6 MICRORNAS FOR MINIMALLY INVASIVE DIAGNOSIS OF PROSTATE CANCER
Boris Alekseev et al.
JOURNAL OF UROLOGY (2017)
Prostate Cancer - Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual
Mark K. Buyyounouski et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
miRNAs as novel biomarkers in the management of prostate cancer
Xavier Filella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1
Joao Ramalho-Carvalho et al.
CANCER LETTERS (2017)
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Caterina Catalanotto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PSA and beyond: alternative prostate cancer biomarkers
Sharanjot Saini
CELLULAR ONCOLOGY (2016)
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis
Olivia Larne et al.
CARCINOGENESIS (2015)
Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma
Yang Wen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis
Xin Zhang et al.
PROSTATE INTERNATIONAL (2015)
Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1α Pathways Synergistically Inhibits Castration-Resistant Prostate Cancer Cells
Elena V. Fernandez et al.
MOLECULAR PHARMACOLOGY (2015)
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
H-M Lin et al.
BRITISH JOURNAL OF CANCER (2014)
Tumor suppressive miRNA-145 inhibits IGF-1 and cell viability in prostate cancer cells
Sanchaika Gaur et al.
CANCER RESEARCH (2014)
Visceral Disease in Castration-resistant Prostate Cancer
Carmel J. Pezaro et al.
EUROPEAN UROLOGY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Profiling of circulating microRNAs for prostate cancer biomarker discovery
Christa Haldrup et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
M. Avgeris et al.
BRITISH JOURNAL OF CANCER (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
K. Boll et al.
ONCOGENE (2013)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
Soichiro Yamamura et al.
PLOS ONE (2012)
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Paivi Ostling et al.
CANCER RESEARCH (2011)
Circulating miRNAs are correlated with tumor progression in prostate cancer
Jan C. Brase et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
Drug resistance in metastatic castration-resistant prostate cancer
Bostjan Seruga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
miR-125b Promotes Growth of Prostate Cancer Xenograft Tumor Through Targeting Pro-Apoptotic Genes
Xu-Bao Shi et al.
PROSTATE (2011)
Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer
Heather Payne et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Transcriptional modulation of micro-RNA in human cells differing in radiation sensitivity
M. Ahmad Chaudhry et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2010)
MiR-34a Attenuates Paclitaxel-Resistance of Hormone-Refractory Prostate Cancer PC3 Cells Through Direct and Indirect Mechanisms
Keitaro Kojima et al.
PROSTATE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease
Elahe A. Mostaghel et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer
Oskar W. Rokhlin et al.
CANCER BIOLOGY & THERAPY (2008)
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
Meng-Lei Zhu et al.
ENDOCRINE-RELATED CANCER (2008)
Predicting survival in patients with advanced disease
Paul Glare et al.
EUROPEAN JOURNAL OF CANCER (2008)
TGF-β signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer
Meng-Lei Zhu et al.
PROSTATE (2008)
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
An E2F/miR-20a autoregulatory feedback loop
Yannick Sylvestre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
分享论文
